跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VYVGART efgartigimod alfa 400 mg/20 mL concentrated injection for intravenous infusion vial - TGA Drug Approval Details
Approvals
/
TGA
/
VYVGART efgartigimod alfa 400 mg/20 mL concentrated injection for intravenous infusion vial
Approved
STANDARD
VYVGART efgartigimod alfa 400 mg/20 mL concentrated injection for intravenous infusion vial
Argenx Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
04e68d9b37144325
Company
Argenx Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
04e68d9b37144325
Product Name
VYVGART efgartigimod alfa 400 mg/20 mL concentrated injection for intravenous infusion vial
Artg Id
444955
Artg Name
VYVGART efgartigimod alfa 400 mg/20 mL concentrated injection for intravenous infusion vial
Sponsor
Argenx Australia Pty Ltd
Company Detail Path
/organization/argenx-australia-pty-ltd
Artg Date
2025-02-24
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2025-CMI-01269-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2025-PI-01271-1
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
04e68d9b37144325
Type
Standard
Back to TGA Approvals